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AbstrAct
Objectives To determine whether the impact of guided 
self-determination (GSD) applied in group training (GSD-
GT) in people with chronically elevated HbA1c and type 1 
diabetes mellitus (DM) was superior to ‘care as usual’ in 
improving HbA1c and psychological functioning.
Setting An outpatient clinic at a university hospital in 
Western Norway.
Participants A total of 178 adults (all Caucasian) 
aged 18–55 (mean age 36.7±10.7, 62% women) with 
type 1 DM for at least 1 year and HbA
1c ≥64 mmol/mol 
(8.0%) were randomly assigned to participate in either 
GSD-GT or a control group (CG). Exclusion criteria were 
severe comorbidity, major psychiatric disorder, cognitive 
deficiency/language barriers and pregnancy.
Intervention Intervention group met seven times for 2 
hours over 14 weeks to promote patient autonomy and 
intrinsic motivation using reflection sheets and advanced 
professional communication in accordance with the GSD 
methodology.
Primary and secondary outcome measures The 
primary outcome was HbA
1c and secondary outcomes 
(all outcomes 9 months post intervention) were self-
monitored blood glucose frequency, self-reported diabetes 
competence, autonomy support by healthcare providers 
(Health Care Climate Questionnaire), autonomous 
versus controlled diabetes motivation (Treatment Self-
Regulation Questionnaire), diabetes distress (Problem 
Areas In Diabetes Scale (PAID) and Diabetes Distress Scale 
(DDS)), self-esteem (Rosenberg Self-Esteem Scale) and 
psychological well-being (World Health Organization five-
item Well-Being Index scale).
Results Among participants allocated to the GSD-GT 
(=90) 48 completed the study, whereas 83 completed in 
the CG (n=88). With 95% CIs GSD-GT did not have effect 
on HbA
1c (B −0.18, CI (−0.48, 0.12), p=0.234). GSD-GT 
improved autonomy-motivated behaviour (B 0.51, CI (0.25, 
0.77), p<0.001), diabetes distress (PAID, B −6.96, CI 
(−11.40, −2.52), p=0.002), total DDS (B −5.15, CI (−9.34, 
−0.96), p=0.016), DDS emotional burden (B −7.19, CI 
(−13.20, −1.19), p=0.019) and self-esteem (B 1.43, CI 
(0.34, 2.52), p=0.011).
Conclusions Results from this behavioural intervention 
must be interpreted cautiously because of recruitment 
and attrition problems. Medical outcomes did not improve. 
Psychological outcomes improved, especially reduced 
diabetes distress.
Trial registration number Clinical  Trials. gov NCT 
01317459.
InTroducTIon
Diabetes is considered a demanding condi-
tion requiring complex self-management 
tasks for the individual. Effective self-man-
agement is a prerequisite for preventing 
long-term complications and the imme-
diate risk of hypoglycaemia. Researchers 
underscore that diabetes self-management 
education is an ongoing process rather 
than a one-time event.1 American Diabetes 
Association (ADA) National Standards for 
Diabetes Self-Management Education and 
Support holds that self-management does 
not stop when a person with diabetes leaves 
the educator’s office.2 Consequently, moti-
vation is a key concept, and one based on 
respect for the individual’s autonomy is 
Strengths and limitations of this study
 ► This study evaluated the effect of a person-centred 
behavioural intervention among adults with type 1 
diabetes mellitus (DM), scarcely evaluated in the 
literature compared with educational programmes 
among persons with type 2 DM.
 ► Targeting persons with type 1 DM and chronically 
elevated HbA1c is a challenge because long-standing 
poor glycaemic control appears to be a complex and 
heterogeneous phenomenon.
 ► The most obvious limitation of this study is 
that generalisability might be distorted due to 
recruitment problems, and attrition from the GSD-
GT (guided  self-determination applied in group 
training) programme.
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essential as it is connected with success in reaching and 
maintaining goals.3 Therefore, the challenge for health-
care professionals (HCPs) is to implement an autonomy 
supportive approach instead of one based on control or 
disclaimed responsibility.4 Considerable barriers to such 
an approach exist5 and personal problems in living with 
the illness might remain unclarified and unresolved.6 
This can contribute to the 37%-56% of people with type 
1 diabetes mellitus (DM) who are living with blood sugar 
above target levels7 and at increased risk of late complica-
tions together with poor quality of life.8 The ADA states 
that diabetes care is often suboptimal; lacking are collab-
orative, multidisciplinary teams well suited to provide 
appropriate self-management education among persons 
with diabetes.9
One of the first structured diabetes treatment and educa-
tion programmes for type 1 DM was developed between 
1980 and 1990.10 While many trials have evaluated the 
effect of diabetes education programmes in type 2 DM, 
there is still a paucity of trials evaluating evidence-based 
self-management programmes promoting empowerment 
in adults with type 1 DM.11 Among persons with type 1 
DM, the DAFNE (Dose Adjustment for Normal Eating) 
education programme showed significant improvements 
in HbA1c in the early stage of the trial
12 but more modest 
longer term improvements.13 A self-management-ori-
ented education programme (PRIMAS) showed effect 
on glycaemic control and reduced diabetes distress at 
6 months of follow-up compared with an established 
education programme in a multicentre trial.14 In an 
uncontrolled evaluation of the DTTP (Diabetes Teaching 
and Treatment Programme) persons with moderately 
controlled type 1 DM improved their HbA1c and treat-
ment satisfaction.15
Guided self-determination (GSD) is a theory-based and 
evidence-based problem-solving method to overcome 
barriers to collaborative care. It is based on life skills 
theory, dynamic judgement building and theories about 
behaviour change. GSD promotes patient autonomy, 
participation, skills building and intrinsic motivation.16 
The method is applicable in group training (GSD-GT) 
or individual care for a variety of conditions. In a recent 
study, GSD improved physical well-being in women surgi-
cally treated for gynaecological cancer.17 For persons with 
type 1 DM, the GSD methodology has demonstrated some 
success. The first randomised controlled trial among 
adults showed significant improvement in glycaemic 
control and life skills.18 In later studies, GSD proved to 
be either borderline effective or not effective concerning 
glycaemic control among younger adults/adolescents; 
however, it reduced diabetes distress and lack of motiva-
tion and improved diabetes competence among young 
adult women.19 20 In addition, a case report on a young 
woman showed considerable reduction in HbA1c after a 
GSD intervention.21 In conclusion, GSD seems worthy 
of further research for several reasons. First, patient 
involvement and person-centred care are highly appre-
ciated and recommended, but difficult to implement as 
part of clinical care.22 Second, GSD is one of few inter-
ventions which clinicians are able to facilitate in routine 
clinical care after rather short training. Third, persons 
with diabetes have a primary role in GSD, spending their 
time at home clarifying what is important for them to 
change and becoming able to express their thoughts in 
communication with HCPs. Consequently, efficiency of 
patient–provider communication increases without extra 
use of HCP resources. Last, GSD has the potential for 
improvement of HbA1c, as well as increased self-determi-
nation and decrease of diabetes-related burden.18 This 
randomised intervention study tests whether GSD-GT is 
superior to ‘care as usual’ (CU) in improving glycaemic 
control and psychological functioning among adults with 
suboptimally regulated type 1 DM.
PaTIenTs and meThods
design
This study was a prospective, randomised trial with a 
control group (CG) and a treatment group. Participants 
were recruited from an outpatient setting at a university 
hospital in Western Norway. The hospital’s population is 
ethnically homogeneous, and includes both urban and 
rural populations. To test the effect of GSD, persons with 
type 1 DM and suboptimal metabolic control were invited 
to participate in an educational group treatment inter-
vention (GSD-GT) or CU CG. The Regional Committee 
for Medical and Health Research Ethics approved the 
study (approval number 2010/1325), and gave access to 
the age, gender and HbA1c of non-responders. Partici-
pants gave written informed consent.
recruitment
From March 2011 to March 2013, all persons with type 
1 DM attending consultations at the university hospital 
(n=561) were assessed for eligibility according to the 
inclusion criteria (figure 1). Further details on inclu-
sion and exclusion criteria are outlined elsewhere.23 A 
prestudy power calculation for a t-test assuming a 0.05 
significance level and a power of 0.8 expecting 25% 
dropout and a difference of 0.6% change in HbA1c (SD 
1.3) between groups led to 218 participants needed to 
include. Expected change in HbA1c was based on clinical 
relevance.
After identifying 476 people who met study criteria, 
a request was sent by post 1–3 weeks in advance of their 
next clinical consultation, inviting them to take part in the 
study. To those who neither responded to the request nor 
attended at the clinic appointment, an additional letter 
was sent. If still no response nor attendance at the clinic, 
they were classified as non-responders (n=149). Another 
149 persons actively declined participation. Their response 
was given when they were at the clinic, or by telephone if 
they were unable to meet for their scheduled appointment. 
Those willing to participate were consented when they were 
at the clinic (n=178). The participation rate in the study 
was 37.4% (178 of the 476 who met inclusion criteria). 
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Participants received no monetary incentives. All sessions 
were free of charge.
randomisation
The randomisation occurred externally and was stratified in 
computer-generated sequences unknown to the investiga-
tors. Blinding was considered impossible due to the nature 
of the intervention and was not attempted. Participants 
were randomised to either the usual care CG (n=88; 
M/W: n=40/48) or GSD-GT (n=90; M/W: n=26/64). The 
groups consisted of a minimum of two and a maximum of 
seven participants. Each GSD training group was balanced 
according to sex and age, preferably an equal number of 
men and women in each group and age ranging ±6 years.
In the CG and GSD-GT conditions, 5 and 42 partic-
ipants were lost to follow-up, respectively; thus 131 
Figure 1 Study flow diagram. GSD, guided self-determination.
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participants (74%) completed the trial. The reasons 
for dropout in both study groups, and the total flow of 
participants through each stage of the trial are depicted 
in figure 1.
Intervention
The GSD intervention was based on a technique by which 
the HCPs encourage people with diabetes to reflect 
on different problem areas concerning their daily lives 
with diabetes and develop autonomous motivation for 
lifestyle changes. The technique was partly built on semi-
structured worksheets filled in before and between each 
appointment, making the people with diabetes prepared 
with enhanced self-insight and ability to talk about 
personal difficulties. The perceived obstacles and barriers 
were responded to by HCPs with specific communication 
skills who conducted each consultation consistent with 
the GSD methodology.18 Intervention group (IG) partic-
ipants met seven times for 2-hour sessions over 14 weeks. 
Two GSD-trained diabetes specialist nurses supervised 
each session. Nurses were given 1 hour per week group-
based feedback to secure fidelity to the protocol. No 
GSD-GT participants received additional treatment 
during the intervention period, except two participants 
who needed one extra consultation because of technical 
problems with their insulin pumps.
The CG received traditional outpatient consultations, 
‘care as usual,’ consisting of individual counselling by 
nurses, physicians or dieticians, with measurements of 
HbA1c and advice on how to improve glycaemic control. 
No CG participants met with GSD-trained nurses during 
the intervention period.
assessments
Participant characteristics were assessed at baseline. 
Primary and secondary outcome measurements were 
planned to be performed at baseline and 9 months 
after the last session of group intervention (GSD-GT) 
or 9 months after inclusion (CG). Because of the need 
to get enough participants to start group sessions, there 
was a large variation in time from randomisation to start 
of intervention in the IG (mean=4.9 months, SD=3.6). 
There was also some variation in time from baseline to 
follow-up in the CG (mean=10.9 months, SD=2.4) and 
time from last session to follow-up in the IG (mean 9.3 
months, SD=1.0) because many participants needed 
several reminders before they handed in the follow-up 
questionnaire.
Primary outcome measure
The primary endpoint was glycaemic control (HbA1c) 
which was assessed in connection with a regularly 
scheduled visit at the hospital. The blood samples were 
analysed using high-performance liquid chromatography 
(DCA Vantage/Siemens, DCA 2000 and DCA 2000+/
Bayer), assays standardised and calibrated against the 
IFCC (International Federation of Clinical Chemists) 
standards.24
secondary outcome measures
All participants reported the number of self-monitored 
blood glucose (SMBG) measurements completed in the 
past 2 weeks in the following six categories: ‘seven or 
more measurements per day’, ‘four to six measurements 
per day’, ‘one to three measurements per day’, ‘less than 
every day’, ‘less than every week’ and ‘no monitoring last 
14 days’. Due to small size of some categories, we chose 
to collapse into the following three categories: ‘seven or 
more measurements per day’, ‘one to six measurements 
per day’ and ‘less than daily measurements’. Participants 
also completed seven self-report instruments assessing 
aspects of psychological functioning consistent with the 
theoretical framework of GSD.
The Problem Areas In Diabetes Scale (PAID) measures 
negative emotions related to living with diabetes 
(range=0–100 scale); higher scores represent greater 
distress.25
The Diabetes Distress Scale (DDS) measures the level of 
diabetes distress with an overall score and four subscales: 
emotional burden, regimen-related, interpersonal-re-
lated and medical care-related distress. The range is 1–6 
for each item. Total score is calculated by transforming 
the mean score to a 0–100 range. Higher scores represent 
greater distress.26
The Perceived Competence for Diabetes Scale (PCDS) assesses 
the degree to which persons with diabetes feel they can 
manage the everyday aspects of diabetes care. The range 
is 1–7 for each item and the mean is used as a total score. 
Higher scores represent greater perceived competence.27
The Rosenberg Self-Esteem Scale (RSES) measures one’s 
overall self-esteem. The range is 1–4 for each item and 
total score is calculated as the mean of all items multi-
plied by 10. Higher scores represent better self-esteem.28
The World Health Organization five-item Well-Being Index 
(WHO-5) measures emotional well-being. The range 
for each item is 0–6 and a total score is calculated by 
transforming the sum to a 0–100 range. Higher scores 
represent better emotional well-being.29
The Health Care Climate Questionnaire (HCCQ) assesses 
patients’ perceptions of the degree to which health-
care providers are supportive of autonomy rather than 
controlling. The range is 1–7 for each item and total 
score is calculated as the mean of all items; higher scores 
represent greater perceived support for autonomy.30
The Treatment Self-Regulation Questionnaire (TSRQ) 
assesses the diabetes self-care practices and whether this 
behaviour is self-motivated (autonomous/internal) or 
controlled (external).31 Each item ranges from 1 to 7 
and behaviour scores are calculated as the mean of items 
within the internal and external dimensions separately. 
A relative autonomy index (TSRQ Relative Autonomy 
Index, RAI) was also calculated.
The PCDS, the HCCQ and the TSRQ were translated 
into Norwegian and back-translated into English by 
professional translators, in accordance with the WHO 
guidelines.32
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statistical analysis
Mann-Whitney U tests and χ2 tests were used to assess 
randomisation efficacy by testing for differences in base-
line measures. To assess differential attrition, members of 
GSD-GT who completed the study were compared with 
those who did not. We fitted a regression model for each 
outcome at 9 months to investigate the difference between 
IG and CG both unadjusted and adjusted for baseline 
outcome and sex. To take into account possible bias intro-
duced by the high attrition rate in the IG, we additionally 
adjusted for variables showing unbalanced attrition. We 
used a linear regression model for all outcomes except 
SMBG where a multinomial logistic model was used. We 
used a linear regression model to test whether change in 
SMBG mediated change in HbA1c and whether psycholog-
ical effects were mediated by increased autonomy.
There were no intermediate assessments of questionnaire 
data; therefore, it was not possible to do intention-to-treat 
analysis for persons who dropped out and per-protocol 
analyses were thus performed. HbA1c was assessed for 
those who did not complete the study because it could 
be obtained from medical records. Therefore, intention-
to-treat analysis of HbA1c was performed. Because of the 
difference in follow-up time between GSD-GT and CG 
and because of the large variation within each group, we 
also did additional analyses where we estimated the asso-
ciation between change in outcome measures and length 
of follow-up within each group. Associations were tested 
using linear regression with change in outcome measure 
as dependent variable and follow-up time in months 
as independent variable with adjustment for baseline 
measurement of the outcome variable. For data analyses, 
the statistical software program SPSS Statistics V.22 (SPSS 
Inc.) was used. Significance level was set to 0.05. Missing 
values were handled by pairwise exclusion.
resulTs
Baseline characteristics
The mean age of all subjects in the study sample was 36.7 
years (±10.7), the median disease duration was 19 years 
(range=1–46), 13.5% were unemployed, 96.6% were white 
and 31.5% had diabetes-related complications. A compar-
ison of the baseline characteristics between the groups 
(without taking the attrition rate into account) suggests 
that the randomisation was successful for all parameters 
except sex, in that we found a significant difference in the 
number of women assigned to the study groups (M/W 
in the GSD-GT: n=26/64 (29/71%) vs M/W in the CG: 
n=37/46 (45/55%), p=0.022) (results not shown). Base-
line characteristics of the sample are presented in table 1.
Due to the considerable number of dropouts in 
GSD-GT, participants were stratified into follow-up and 
lost to follow-up to analyse the effects of attrition. The 
only statistically significant difference at baseline between 
CG and GSD-GT follow-up was for sex (p=0.047). The 
GSD-GT lost to follow-up participants had poorer base-
line glycaemic control and scored higher on diabetes 
distress (DDS, subscale 3, regimen distress) than GSD-GT 
follow-up participants. Similarly, there were significantly 
fewer persons with education at a university level in the 
GSD-GT lost to follow-up group than in the GSD-GT 
follow-up group.
Among participants allocated to the CG, there were no 
statistically significant baseline differences between those 
who fulfilled the trial (n=83) and those who were lost to 
follow-up (n=5, data not shown).
Primary outcome
As seen in table 2, HbA1c declined significantly within 
both groups (p<0.001) from baseline to follow-up, with 
no significant difference between the groups.
secondary outcomes
The results for all secondary outcome measures are 
presented in table 2, except SMBG (table 3). Secondary 
outcomes are clustered into (A) medical measures, (B) 
type of motivation and (C) psychological measures.
Medical measures
The proportion of SMBG seven times per day or more 
increased significantly within both groups from base-
line to follow-up. There was no significant difference 
between groups in change at follow-up. The change 
of HbA1c was not mediated by the change of SMBG 
(p=0.728, data not shown). Self-perceived diabetes 
competence (PCDS) and autonomy support from HCPs 
(HCCQ) showed no significant change, neither within 
nor between groups.
Type of motivation
The TSRQ Relative Autonomy Index showed a signifi-
cant improvement within the GSD-GT group (p=0.014), 
and a significant difference between groups in change 
(B=0.35, p=0.045). This finding was due primarily to a 
significant improvement in TSRQ Autonomy for GSD-GT 
relative to CG (B=0.51, p<0.001). TSRQ control remained 
unchanged within both groups, with no significant differ-
ence between groups.
Psychological measures
Participants in the GSD-GT group exhibited a signifi-
cant reduction in diabetes-related distress relative to the 
CG as measured by the PAID, the DDS overall score and 
the DDS emotional burden subscale (B=−6.96, p=0.002; 
B=−5.15, p=0.016; and B=−7.19, p=0.019 respectively). 
In addition, a reduction in DDS regimen distress was 
reported within the GSD-GT group as well as the CG; 
the difference in group improvement did not reach 
significance. The GSD-GT group showed an increase in 
self-esteem (RSES) relative to the CG (B=1.43, p=0.011); 
the CG experienced a decrease in self-esteem (p=0.027). 
The level of overall well-being (WHO-5) showed no 
significant change, neither within nor between the study 
groups. Neither PAID, DDS total nor RSES was signifi-
cantly mediated by TSRQ autonomy (p>0.070, data not 
shown).
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length of follow-up
Results from linear regression analyses for the association 
between outcome measures and length of follow-up in 
the IG are shown in table 4. There were no significant 
associations, that is, the change was not larger for patients 
with longer follow-up. Corresponding analyses for the 
CG also showed no significant associations with length of 
follow-up (results not shown).
Table 1 Baseline characteristics of control group versus guided self-determination (GSD) intervention group (N=173)
A. Control group 









Lost to follow-up 
n=42 p p
Participant characteristics
Sex, women a b 46 (55.4) 35 (72.9) 29 (69.0) 0.047 0.686
Age, yearsc d 37.2 (10.9) 36.9 (9.4) 36.3 (11.6) 0.860 0.916
Living alone, yes a b 17 (20.5) 5 (10.4) 6 (14.3) 0.138 0.576
Education university, yes a b 30 (36.1) 23 (47.9) 10 (23.8) 0.186 0.018
Employed a b
  Full-time 54 (65.1) 34 (70.8) 28 (66.7) 0.485 0.464
  Part-time 16 (19.3) 10 (20.8) 7 (16.7)
  Not working 13 (15.7) 4 (8.3) 7 (16.7)
Diabetes duration, years  c d 20.6 (11.2) 18.5 (10.6) 18.0 (11.0) 0.310 0.694
Long-term complications, yes a b 29 (34.9) 11 (22.9) 15 (35.7) 0.150 0.181
Treatment regimen, insulin pump, yes a b 37 (44.6) 16 (33.3) 20 (47.6) 0.206 0.168
Severe hypoglycaemia, yes a b 35 (42.7) 24 (50.0) 13 (31.7) 0.419 0.081
Body Mass Index (BMI) c d  26.0 (4.1) 25.0 (3.6) 25.8 (4.0) 0.145 0.333
Outcomes
HbA1c, mmol/mol 
c d  78 (12.7) 76 (10.4) 81 (11.7)
HbA1c, % 
c d  9.3 (1.2) 9.1 (1.0) 9.5 (1.1) 0.320 0.018
SMBGa b e
  ≥7 times per day 8 (9.6) 8 (16.7) 5 (11.9) 0.439 0.627
  1–6 times per day 51 (61.4) 29 (60.4) 24 (57.1)
  <Every day 24 (28.9) 11 (22.9) 13 (31.0)
PAID c d f 35.3 (18.7) 36.8 (19.3) 41.6 (24.4) 0.696 0.355
DDS c d g (sum score) 31.9 (16.7) 33.1 (16.4) 37.3 (20.9) 0.643 0.340
DDS emotional burden  c d 36.0 (22.5) 36.9 (25.6) 42.3 (26.0) 0.985 0.297
DDS physician distress c d  17.7 (19.9) 18.1 (18.2) 19.7 (23.1) 0.826 0.990
DDS regimen distress  c d 45.8 (23.7) 44.7 (21.8) 53.9 (25.4) 0.816 0.036
DDS interpersonal distressc d  21.0 (20.1) 26.1 (19.3) 24.9 (23.2) 0.101 0.577
PCDS c d h 4.5 (1.6) 4.4 (1.4) 3.9 (1.6) 0.734 0.088
RSES  c d i 19.6 (5.5) 19.5 (5.4) 19.0 (6.2) 0.876 0.624
WHO-5 c d j 57.6 (18.6) 60.9 (19.8) 57.1 (20.5) 0.338 0.468
HCCQ c d k 5.1 (1.4) 4.9 (1.6) 4.8 (1.6) 0.595 0.923
TSRQ autonomyc d l 5.2 (1.1) 5.4 (1.0) 4.9 (1.3) 0.754 0.088
TSRQ control c d m 3.2 (1.3) 3.5 (1.2) 3.1 (1.2) 0.073 0.061
TSRQ RAI 14 c d n 2.0 (1.3) 1.8 (1.5) 1.8 (1.7) 0.339 0.588
aN (%),  bChi-square (χ2), cMean (SD),dMann-Whitney, eSelf-Monitoring Blood Glucose, fProblem Areas in Diabetes scale (range 0-100), 
gDiabetes Distress Scale (range 0-100), hPerceived Competence in Diabetes Scale (range 1-7), iRosenberg Self-Esteem Scale (range 10-
40), jWHO(5)Well-being Index (range 0-100),kHealth Care Climate Questionnaire (range 1-7), lTreatment Self-Regulation Questionnaire, 
Autonomous motivation (range 1-7), mTreatment Self-Regulation Questionnaire, Controlled motivation (range 1-7), nTreatment Self-Regulation 
Questionnaire, Relative Autonomy Index (range 0-6).
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dIscussIon
statement of the principal findings and possible 
explanations
Contrary to the study hypothesis, a group-based GSD 
programme among persons with type 1 DM and chron-
ically elevated HbA1c did not improve the medical 
outcomes (glycaemic control, frequency of SMBG, 
perceived competence for diabetes management, percep-
tion of HCPs being supportive of patient autonomy). The 
hypothesis regarding improvement of psychological func-
tioning was partly confirmed, with improvement in the 
level of autonomy-motivated behaviour, diabetes distress 
and self-esteem, but not the level of general psychological 
well-being.
Long-standing elevated HbA1c appears to be a complex 
and heterogeneous phenomenon33 and educational 
programmes have been evaluated for their effectiveness 
for improving glycaemic control.13 34 35 Some researchers 
indicate that evaluation studies need to better under-
stand the complexity of variance in HbA1c.
36 The present 
study revealed a substantial decrease in HbA1c in both 
groups, with no difference between groups. It is likely 
that the change in CG HbA1c was driven by the ‘observer 
effect,’ that is, that individuals modify or improve their 
behaviour in response to their awareness of being 
observed.37 Additional measures of quality of metabolic 
control would have been follow-up data on mild or severe 
hypoglycaemia, but these were not assessed.
strengths of the study in relation to other studies
The GSD-GT intervention demonstrated a signifi-
cant improvement in diabetes distress. There were no 
between-group differences in diabetes distress at baseline 
among those completing the study. The GSD-GT study 
group consisted of persons with a rather substantial level 
of self-reported diabetes distress (43% scoring ≥40 on the 
PAID scale) at baseline, comparable to previous research.19 
Our results confirm that although a behavioural interven-
tion may not improve medical outcomes among persons 
with persistently elevated HbA1c psychological outcomes 
may improve. This raises the possibility that if interven-
tions resulting in behaviour change also reduce diabetes 
distress, the gains in diabetes self-management might be 
sustained over the long term, as argued by Zagarins et al.38 
One of the key elements of GSD is to support persons with 
diabetes to clarify and express their unique difficulties 
and barriers to healthy coping. This is done by mobil-
ising their own potential for change in interactions with 
autonomy supportive HCPs and by using semistructured 
reflection sheets. Instead of being instructed by HCPs, 
Table 3 Outcomes for SMBG in control group and GSD intervention group (N=131)
Within-group changea Between-groups changeb c












  ≥7 times per 
day
8 (9.6%) 54 (65.9%) <0.001 8 (16.7%) 34 (72.3%) <0.001 1.02 (0.35 
to 2.95)
0.971 0.92 (0.31 
to 2.74)
0.887
  1–6 times 
per day
51 (61.4%) 10 (12.2%) 29 (60.4%) 8 (17.0%) 1 1
  <Daily 24 (28.9%) 18 (22.0%) 11 (22.9%) 5 (10.6%) 3.38 (0.65 
to 17.58)
0.148 3.12 (0.57 
to 16.97)
0.189
aAll within-group change values referred as χ2, bModel 1: adjusted for baseline value of outcome. Model 2: adjusted for baseline value of 
outcome and sex, cOR from multinomial logistic regression.
GSD, guided self-determination; SMBG, self-monitored blood glucose.






Mean (SD) Bb p Value
HbA1c, % 87 16.1 (5.6) −0.51 (1.21) −0.03 0.154
PAIDc 47 17.6 (3.6) −6.7 (13.8) −0.2 0.764
DDSdoverall 47 17.6 (3.6) −5.4 (14.0) −0.4 0.542
DDS emotional burden 48 17.6 (3.6) −7.1 (20.1) 0.1 0.945
RSESe 47 17.6 (3.6) 0.6 (3.5) −0.1 0.435
TSRQ autonomyf 49 17.6 (3.6) 0.2 (0.9) 0.03 0.388
aTotal follow-up time from date of randomization measured in months, bB=unstandardized regression coefficients, cProblem Areas in Diabetes 
scale, dDiabetes Distress Scale, eRosenberg Self-Esteem Scale, fTreatment SelfRegulation Questionnaire, Autonomous motivation.
 GSD, guided self-determination; 
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the core principle in GSD is individualised goal setting, 
a treatment strategy comparable to other behavioural 
interventions.14 In a cross-sectional study, HCPs being 
autonomy supportive were associated with the perceived 
level of diabetes distress mediated through the perceived 
level of diabetes competence.23 In the current study, and 
incongruent with prior research on the GSD approach,18 19 
there was no change in HCP autonomy support (HCCQ) 
and level of diabetes competence (PCDS). However, GSD 
increased autonomous motivation (TSRQ autonomy) 
and reduced diabetes distress. In terms of patient 
outcomes, improvement of autonomous motivation 
for change is hypothesised to be the key mechanism; 
autonomy support from HCPs is merely one strategy for 
activating that mechanism. Although the mediation anal-
ysis in the current study did not confirm that increasing 
autonomy mediates mental health benefits (PAID, DDS 
total and RSES), the individual’s use of reflection sheets 
may play a more important role in GSD. This interpre-
tation is consistent with a recently published qualitative 
paper evaluating how a GSD approach could bring about 
a dramatic change in a young woman’ s perception of her 
diabetes.21
Weaknesses of the study and future research
The most obvious limitation of this study is that general-
isability might be distorted due to recruitment problems 
and attrition from the GSD-GT programme. As the 
power calculation premise was violated, the interpreta-
tion of the results is challenging. It remains to a certain 
extent unclear whether the results are attributable to 
insufficient power, differential attrition or the effect 
of the intervention. However, there was no significant 
difference in change in HbA1c between GSD-GT partici-
pants who completed the study versus those who did not 
(p value from t-test 0.71), indicating that it was not the 
participants with the poorest effect of the intervention 
who dropped out. Because of lacking follow-up question-
naires we were not able to do the same test for psychosocial 
measurements, but it is reasonable to assume that differ-
ences between dropouts and completers would mirror 
what we found for HbA1c.
Nevertheless, it is worthwhile to consider potential 
reasons for high rates of attrition in the IG. Only four 
participants dropped out after attending a GSD session, 
comparable to the two participants in the CG who did 
not make their follow-up medical visits. Most of the drop-
outs in the GSD-GT group did not attend a single session 
(33/39), suggesting some possible interpretations for this 
postrandomisation/preparticipation attrition:
The time from randomisation to start of GSD-GT 
(mean 4.9 months, SD=3.6) could perhaps discourage 
individuals who were highly motivated by time of rando-
misation but considered the waiting time to be too long 
until the GSD-GT started. Another aspect might be that 
some individuals found the intervention too comprehen-
sive and demanding after more detailed information was 
given with regard to the preintervention worksheets that 
participants were encouraged to fill in before each group 
session.
Another limitation is the difference in length of 
follow-up between the GSD-GT group and the CG. We did 
however not find any association between the changes in 
outcomes and length of follow-up in the two groups. Thus, 
we do not think that the longer follow-up in the GSD-GT 
group can explain the reported effects of the interven-
tion. In addition, frequency of blood sugar measurement 
was measured using a rather crude categorisation which 
might cause loss of important information. Using SMBG 
as a continuous variable would have been optimal as that 
would have offered a between-group comparison of the 
absolute number of measurements per day. However, 
when designing this study we considered the variation in 
demands of the disease to differ too much from one day 
to another, making it difficult to give a valid estimate of 
the number of measurements per day. We thus choose to 
use a variable with six categories, but had to collapse this 
into three categories because of few patients in each cate-
gory. We tried different categorisations but did not find 
any significant intervention effect.
Consistent with previous studies, targeting distressed 
persons with diabetes39 can be difficult because those 
with the greatest need for psychological support are 
most likely to drop out of the psychological intervention. 
Conversely, those who completed the study had lower 
levels of diabetes distress and HbA1c at baseline, reflecting 
less need for improvement of competence to manage the 
everyday aspects of their diabetes care. Perhaps future 
research on behavioural interventions, especially GSD, 
should assess patient interest in making changes prior to 
randomisation so that study participants are appropriate 
for the intervention.
In the present study, the failure to achieve the primary 
study goal could possibly be explained by incongruence 
between the research focus on medical outcomes and 
participants’ possibly prioritising aspects of life other 
than clinical improvements. Consequently, it is important 
to assess individual goals in future research using person-
alised approaches to improving outcomes. In line with 
the DAWN2 study, there are still unmet needs of people 
with diabetes and those who care for them, and promo-
tion of innovative efforts to improve self-management 
and life skills performance should be facilitated.40 Efforts 
to manage emotional distress have been suggested as an 
integral part of diabetes care.41 Improving psychosocial 
outcomes requires a shift away from a purely medical 
model to a person-centred model with greater emphasis 
on psychosocial aspects. Barnard and colleagues have 
advocated a holistic model of diabetes care aiming at 
enhanced diabetes self-management and improved 
outcomes by considering intrinsic thoughts, as well as the 
environment and therapy regimen.42
Implications for clinicians
The present study exemplifies a complex behavioural 
intervention with feasibility challenges and does not 
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confirm improvements in HbA1c and other medical 
outcomes. However, autonomous motivation improved 
and might be one mechanism for reducing diabetes 
distress.
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